Items where Author is "Weinstein, Vera"

Article

Hussaarts, Leonie and Mühlebach, Stefan and Shah, Vinod P. and McNeil, Scott and Borchard, Gerrit and Flühmann, Beat and Weinstein, Vera and Neervannan, Sesha and Griffiths, Elwyn and Jiang, Wenlei and Wolff-Holz, Elena and Crommelin, Daan J. A. and de Vlieger, Jon S. B.. (2017) Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Annals of the New York Academy of Sciences, 1407 (1). pp. 39-49.

Mühlebach , Stefan F. and Shah, Vinod P. and McNeil, Scott E. and Borchard, Gerrit and Weinstein, Vera and de Vlieger , Jon S. B. and Flühmann, Beat and Crommelin, Daan J. A. and Neervannan, Sesha. (2015) NBCDS and their follow-on versions: time for an editorial section (perspective). Generics and Biosimilars Initiative Journal, 4 (4). pp. 167-170.

Crommelin, Daan J. A. and Shah, Vinod P. and Klebovich, Imre and McNeil, Scott E. and Weinstein, Vera and Flühmann, Beat and Mühlebach, Stefan and de Vlieger, Jon S. B.. (2015) The similarity question for biologicals and non-biological complex drugs. European journal of pharmaceutical sciences, 76. pp. 10-17.

Crommelin, Daan J. A. and de Vlieger, Jon S. B. and Weinstein, Vera and Mühlebach, Stefan and Shah, Vinod P. and Schellekens, Huub. (2014) Different pharmaceutical products need similar terminology. The AAPS journal, 16 (1). pp. 11-14.

Schellekens, Huub and Stegemann, Sven and Weinstein, Vera and de Vlieger, Jon S. B. and Flühmann, Beat and Mühlebach, Stefan and Gaspar, Rogério and Shah, Vinod P. and Crommelin, Daan J. A.. (2014) How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider. The AAPS journal, 16 (1). pp. 15-21.